Skip to content

Clinical Trial Using Health Drink

To evaluate safety of Mulmina Health Drink between two doses of COVID-19 Vaccine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035747
Enrollment
300
Registered
2021-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Mulmina a multi- mineral and multi- vitamin health drink: 2 tetra packs of 200 mL each per day for 28 days between 1st and 2nd dose of Covid- 19 vaccine Control Intervention1: Healthy C

Sponsors

Juggat Pharma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects who meet the following criteria will be included in the study: ïÆ?¼ Males and females >18 and ïÆ?¼ Subjects willing to consume Mulmina energy drink regularly: 2 Tetra Packs of 200 mL each per day for 28 days

Exclusion criteria

Exclusion criteria: Subjects who meet the following criteria will be excluded from the study: ïÆ?¼ Pregnant or lactating women ïÆ?¼ Any acute gastrointestinal disease within 2 weeks prior to study entry ïÆ?¼ Cancer cachexia ïÆ?¼ Patients suffering from chronic illness ïÆ?¼ Untreated major psychiatric disorder ïÆ?¼ Known HIV positive ïÆ?¼ Hepatitis B & C

Design outcomes

Primary

MeasureTime frame
Change in COVID 19 Antibodies & Immune markers level after consumption of Mulmina health drinkTimepoint: Zero Day Screening and Baseline Twenty eighth day Laboratory analysis

Secondary

MeasureTime frame
Change in Antioxidants level Complete blood count, Lipid profile & LFT parameters Timepoint: Zero Day Screening and Baseline Twenty eighth day Laboratory analysis

Countries

India

Contacts

Public ContactDr Shashidhar K N

Sri Devaraj Urs Medical College

drshashikn1971@yahoo.co.in9845248742

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026